This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Warszawski Uniwersytet Medyczny. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Krzysztof Bojakowski: Innovator in Pharmaceutical Chemistry
Introduction
Krzysztof Bojakowski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative approach to vascular disorders.
Latest Patents
Krzysztof Bojakowski holds a patent for a compound that includes a protoescigenin derivative, which exhibits pharmacological properties. This patent, titled "Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound," details a specific process for preparing the compound, as well as its applications as a medicament for treating vascular disorders.
Career Highlights
Krzysztof works at the Medical University of Warsaw, where he applies his expertise in pharmaceutical research. His innovative work is pivotal in developing therapeutic solutions that address critical health issues, particularly in vascular health.
Collaborations
Throughout his career, Krzysztof has collaborated with a talented team, including coworkers Katarzyna Koziak and Magdalena Kowalewska. Together, they strive to advance research and develop new pharmaceutical solutions that can benefit a wide range of patients.
Conclusion
Krzysztof Bojakowski stands out as an impactful inventor in the medical field, significantly contributing to innovation in treatments for vascular disorders. His research and patents represent important strides in pharmacology and highlight the role of collaborative efforts in driving progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile